MENU

XBIO Xenetic Biosciences Forecast, Technical & Fundamental Analysis

a developer of biologic drugs, novel oncology therapeutics, and vaccinations

Industry Biotechnology
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published Earnings

XBIO is expected to report earnings to rise 10.00% to -10 cents per share on May 17

Xenetic Biosciences XBIO Stock Earnings Reports
Q1'23
Est.
$-0.11
Q4'22
Est.
$-0.10
Q3'22
Est.
$-0.06
Q2'22
Est.
$-0.19
Q1'22
Est.
$-0.12
The last earnings report on March 23 showed earnings per share of -10 cents, meeting the estimate of -10 cents. With 640.00 shares outstanding, the current market capitalization sits at 5.88M.
A.I. Advisor
published General Information

General Information

a developer of biologic drugs, novel oncology therapeutics, and vaccinations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
945 Concord Street
Phone
+1 781 778-7720
Employees
4
Web
https://www.xeneticbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

XBIO and Stocks

Correlation & Price change

A.I.dvisor tells us that XBIO and ALZN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XBIO and ALZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIO
1D Price
Change %
XBIO100%
-5.35%
ALZN - XBIO
24%
Poorly correlated
+2.13%
ABUS - XBIO
24%
Poorly correlated
+3.10%
GOSS - XBIO
23%
Poorly correlated
-1.20%
UBX - XBIO
23%
Poorly correlated
-4.91%
SNDX - XBIO
23%
Poorly correlated
-0.05%
More

Groups containing XBIO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIO
1D Price
Change %
XBIO100%
-5.35%
XBIO
(2 stocks)
80%
Closely correlated
-3.07%
drugs
(265 stocks)
17%
Poorly correlated
+5.37%
biotechnology
(248 stocks)
17%
Poorly correlated
+5.56%
cancer
(87 stocks)
17%
Poorly correlated
+0.89%
challenging disorders
(8 stocks)
15%
Poorly correlated
-2.89%
More